NCT04558294View on ClinicalTrials.gov

Effect of Ketanserin After LSD Administration

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 16, 2020

Primary Completion Date

August 28, 2021

Study Completion Date

September 29, 2021

Conditions
Healthy
Interventions
DRUG

Lysergic Acid Diethylamide

A moderate dose of 100 μg LSD will be administered.

DRUG

Ketanserin Placebo

Mannitol capsules instead of capsules containing Ketanserin.

DRUG

Ketanserin

A dose of 40 mg Ketanserin will be administered.

Trial Locations (1)

4031

Clinical Pharmacology & Toxicology, University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT04558294 - Effect of Ketanserin After LSD Administration | Biotech Hunter | Biotech Hunter